rosiglitazone has been researched along with Brain Inflammation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendayan, R; Choi, UY; Hoque, MT; Omeragic, A | 1 |
| Ballesteros, I; Corbí, ÁL; Cuartero, MI; Hamilton, JA; Lizasoain, I; Moraga, A; Moro, MA; Nombela, F; Vivancos, J | 1 |
| Carta, AR; Casu, MA; Diana, A; Lecca, D; Mulas, G; Nevin, DK; Rossi, D; Sacchetti, G | 1 |
| Allahtavakoli, M; Arababadi, MK; Javanmardi, K; Moloudi, R; Shamsizadeh, A | 1 |
| Carta, AR; Pisanu, A | 1 |
| Bowen, KK; Feinstein, DL; Kapadia, R; Liang, J; Satriotomo, I; Tureyen, K; Vemuganti, R | 1 |
1 review(s) available for rosiglitazone and Brain Inflammation
| Article | Year |
|---|---|
Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Encephalitis; Humans; Microglia; Parkinson Disease; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2013 |
5 other study(ies) available for rosiglitazone and Brain Inflammation
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.
Topics: AIDS Dementia Complex; Animals; Encephalitis; HIV-1; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2017 |
N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone.
Topics: Brain; Encephalitis; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Neutrophils; PPAR gamma; Rosiglitazone; Stroke; Thiazolidinediones | 2013 |
Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Encephalitis; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Lipopolysaccharides; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; NF-kappa B; Parkinsonian Disorders; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Thiobarbiturates; Tyrosine 3-Monooxygenase | 2015 |
Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Topics: Animals; Brain Infarction; Brain Ischemia; Cell Death; Disease Models, Animal; DNA Fragmentation; Encephalitis; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Leukocyte Count; Male; Neuroprotective Agents; Neutrophils; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2009 |
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Topics: Anilides; Animals; Cerebral Infarction; Chemotaxis, Leukocyte; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Encephalitis; Hypertension; Intercellular Adhesion Molecule-1; Ischemic Attack, Transient; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neuroprotective Agents; Pioglitazone; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Superoxide Dismutase-1; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Thiazolidinediones | 2007 |